EMPAVELI

pegcetacoplan · Apellis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for EMPAVELI, covering 2021-05-14 to 2026-08-20. Get the full timeline:

Most recent: FDA Approved: EMPAVELI — Supplemental Application (APELLIS PHARMS)